137 related articles for article (PubMed ID: 18093597)
21. Factors involved in rosuvastatin induction of insulin sensitization in rats fed a high fat diet.
de las Heras N; Valero-Muñoz M; Ballesteros S; Gómez-Hernández A; Martín-Fernández B; Blanco-Rivero J; Cachofeiro V; Benito M; Balfagón G; Lahera V
Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1107-14. PubMed ID: 23434394
[TBL] [Abstract][Full Text] [Related]
22. Rosuvastatin prevents pressure overload‑induced myocardial hypertrophy via inactivation of the Akt, ERK1/2 and GATA4 signaling pathways in rats.
Xu X; Zhang L; Liang J
Mol Med Rep; 2013 Aug; 8(2):385-92. PubMed ID: 23799547
[TBL] [Abstract][Full Text] [Related]
23. Astaxanthin prevents loss of insulin signaling and improves glucose metabolism in liver of insulin resistant mice.
Bhuvaneswari S; Anuradha CV
Can J Physiol Pharmacol; 2012 Nov; 90(11):1544-52. PubMed ID: 23181282
[TBL] [Abstract][Full Text] [Related]
24. Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet.
Fraulob JC; Souza-Mello V; Aguila MB; Mandarim-de-Lacerda CA
Clin Sci (Lond); 2012 Aug; 123(4):259-70. PubMed ID: 22420611
[TBL] [Abstract][Full Text] [Related]
25. A biochemical and functional characterization of diet-induced brain insulin resistance.
Mielke JG; Taghibiglou C; Liu L; Zhang Y; Jia Z; Adeli K; Wang YT
J Neurochem; 2005 Jun; 93(6):1568-78. PubMed ID: 15935073
[TBL] [Abstract][Full Text] [Related]
26. Statin modulates insulin signaling and insulin resistance in liver and muscle of rats fed a high-fat diet.
Lalli CA; Pauli JR; Prada PO; Cintra DE; Ropelle ER; Velloso LA; Saad MJ
Metabolism; 2008 Jan; 57(1):57-65. PubMed ID: 18078859
[TBL] [Abstract][Full Text] [Related]
27. Intravenous rosuvastatin for acute stroke treatment: an animal study.
Prinz V; Laufs U; Gertz K; Kronenberg G; Balkaya M; Leithner C; Lindauer U; Endres M
Stroke; 2008 Feb; 39(2):433-8. PubMed ID: 18162625
[TBL] [Abstract][Full Text] [Related]
28. PTEN upregulation may explain the development of insulin resistance and type 2 diabetes with high dose statins.
Birnbaum Y; Nanhwan MK; Ling S; Perez-Polo JR; Ye Y; Bajaj M
Cardiovasc Drugs Ther; 2014 Oct; 28(5):447-57. PubMed ID: 25106875
[TBL] [Abstract][Full Text] [Related]
29. Low intensity exercise prevents disturbances in rat cardiac insulin signaling and endothelial nitric oxide synthase induced by high fructose diet.
Stanišić J; Korićanac G; Ćulafić T; Romić S; Stojiljković M; Kostić M; Pantelić M; Tepavčević S
Mol Cell Endocrinol; 2016 Jan; 420():97-104. PubMed ID: 26644274
[TBL] [Abstract][Full Text] [Related]
30. Rosuvastatin reduces plasma lipids by inhibiting VLDL production and enhancing hepatobiliary lipid excretion in ApoE*3-leiden mice.
Delsing DJ; Post SM; Groenendijk M; Solaas K; van der Boom H; van Duyvenvoorde W; de Wit EC; Bloks VW; Kuipers F; Havekes LM; Princen HM
J Cardiovasc Pharmacol; 2005 Jan; 45(1):53-60. PubMed ID: 15613980
[TBL] [Abstract][Full Text] [Related]
31. Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injury.
Whaley-Connell A; DeMarco VG; Lastra G; Manrique C; Nistala R; Cooper SA; Westerly B; Hayden MR; Wiedmeyer C; Wei Y; Sowers JR
Am J Nephrol; 2008; 28(1):67-75. PubMed ID: 17914247
[TBL] [Abstract][Full Text] [Related]
32. Myricetin, a naturally occurring flavonol, ameliorates insulin resistance induced by a high-fructose diet in rats.
Liu IM; Tzeng TF; Liou SS; Lan TW
Life Sci; 2007 Nov; 81(21-22):1479-88. PubMed ID: 17976658
[TBL] [Abstract][Full Text] [Related]
33. Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy.
Ii M; Nishimura H; Kusano KF; Qin G; Yoon YS; Wecker A; Asahara T; Losordo DW
Circulation; 2005 Jul; 112(1):93-102. PubMed ID: 15983249
[TBL] [Abstract][Full Text] [Related]
34. Rosuvastatin attenuates atherosclerosis in rats via activation of scavenger receptor class B type I.
Li Y; Wang Q; Zhou J; Xu Q; Chu X; Sun T; Liu X; Cai S
Eur J Pharmacol; 2014 Jan; 723():23-8. PubMed ID: 24333476
[TBL] [Abstract][Full Text] [Related]
35. Rosuvastatin reduces atherosclerotic lesions and promotes progenitor cell mobilisation and recruitment in apolipoprotein E knockout mice.
Schroeter MR; Humboldt T; Schäfer K; Konstantinides S
Atherosclerosis; 2009 Jul; 205(1):63-73. PubMed ID: 19111832
[TBL] [Abstract][Full Text] [Related]
36. Citrus polymethoxylated flavones improve lipid and glucose homeostasis and modulate adipocytokines in fructose-induced insulin resistant hamsters.
Li RW; Theriault AG; Au K; Douglas TD; Casaschi A; Kurowska EM; Mukherjee R
Life Sci; 2006 Jun; 79(4):365-73. PubMed ID: 16497336
[TBL] [Abstract][Full Text] [Related]
37. Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemia.
Lamendola C; Abbasi F; Chu JW; Hutchinson H; Cain V; Leary E; McLaughlin T; Stein E; Reaven G
Am J Cardiol; 2005 Jan; 95(2):189-93. PubMed ID: 15642550
[TBL] [Abstract][Full Text] [Related]
38. Targeted disruption of iNOS prevents LPS-induced S-nitrosation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice.
Carvalho-Filho MA; Ueno M; Carvalheira JB; Velloso LA; Saad MJ
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E476-82. PubMed ID: 16638822
[TBL] [Abstract][Full Text] [Related]
39. Rosuvastatin treatment reverses impaired coronary artery vasodilation in fructose-fed, insulin-resistant rats.
Miller AW; Tulbert CD; Busija DW
Am J Physiol Regul Integr Comp Physiol; 2004 Jul; 287(1):R157-60. PubMed ID: 15044186
[TBL] [Abstract][Full Text] [Related]
40. The effect of HMG-CoA reductase inhibitor on insulin resistance in patients undergoing peritoneal dialysis.
Doh FM; Chang TI; Koo HM; Lee MJ; Shin DH; Kim CH; Ko KI; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
Cardiovasc Drugs Ther; 2012 Dec; 26(6):501-9. PubMed ID: 22956052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
